Guard Therapeutics International AB (publ) (STO:GUARD)

Sweden flag Sweden · Delayed Price · Currency is SEK
19.30
+0.20 (1.05%)
Jul 22, 2025, 1:36 PM CET
-31.54%
Market Cap385.20M
Revenue (ttm)n/a
Net Income (ttm)-115.77M
Shares Out20.17M
EPS (ttm)-9.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,498
Average Volume30,415
Open18.95
Previous Close19.10
Day's Range18.90 - 19.35
52-Week Range11.85 - 33.37
Beta-0.21
RSI57.28
Earnings DateAug 19, 2025

About STO:GUARD

Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known as A1M Pharma AB (publ) and changed its name to Guard Therapeutics International AB (publ) in October 2019. Guard Therapeutics International AB (publ) was incorporated in 2008 and is ba... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 12
Stock Exchange Nasdaq Stockholm
Ticker Symbol GUARD
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.